1/24
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Statistics

RF’s



Screening and Prevention





Screening and Prevention
CT Colonography (CTC)
Pros
Cons

Fecal test

S/Sx



Classification
pMMR/MSS colon cancer
dMMR/MSi-H colon cancer

Common chemotherapy regimens


Adjuvant therapy for
pMMR/MSS CC
dMMR/MSI-H CC

Metastatic treatment of:
pMMR/MSS CC
dMMR/MSI-H CC

Metastasis treatment: target therapy



CEA (Carcinoembruonic antigen)

Oxaliplatin (Eloxatin)
Class
MOA
Indication
Route of admin
Admin schedules

Oxaliplatin (Eloxatin)
Dose
ADRs
Monitoring


Irinotecan
Class
MOA
Indication
Routes of admin

Irinotecan
ADRs
DDIs
Monitoring


Cetuximab (Erbitux)
Class
MOA
Indication

Cetuximab (Erbitux)
Routes of admin
ADRs
Monitoring
Clinical pearls


Bevacizuman (Avastin)
Class
MOA
Indication
Route of admin

Bevacizuman (Avastin)
Admin schedules
ADRs


Bevacizuman (Avastin)
DDis
Monitoring
Clinical pearls

Similar drugs to bevacizumab (2)
Class
Indication

Oral VEGF-targeting agents
Agent
MOA
Indication

Oral VEGF-targetin agents
Agent
Indication
